• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

The translocation t(8;21)(q22;q22) in acute myeloid leukemia (AML) results in the expression of the fusion protein RUNX1/MTG8, which in turn recruits histone deacetylases (HDAC) to silence RUNX1 target genes [e.g., interleukin-3 (IL-3)]. We previously reported that expression of the RUNX1/MTG8 target gene IL-3 is synergistically restored by the combination of inhibitors of HDACs (i.e., depsipeptide) and DNA methyltransferases (DNMT; i.e., decitabine) in RUNX1/MTG8-positive Kasumi-1 cells. Thus, we hypothesized that DNMT1 is also part of the transcriptional repressor complex recruited by RUNX1/MTG8. By a chromatin immunoprecipitation assay, we identified a RUNX1/MTG8-DNMT1 complex on the IL-3 promoter in Kasumi-1 cells and in primary RUNX1/MTG8-positive AML blasts. The physical association of RUNX1/MTG8 with DNMT1 was shown by coimmunoprecipitation experiments. Furthermore, RUNX1/MTG8 and DNMT1 were concurrently released from the IL-3 promoter by exposure to depsipeptide or stabilized on the promoter by decitabine treatment. Finally, we proved that RUNX1/MTG8 and DNMT1 were functionally interrelated by showing an enhanced repression of IL-3 after coexpression in 293T cells. These results suggest a novel mechanism for gene silencing mediated by RUNX1/MTG8 and support the combination of HDAC and DNMT inhibitors as a novel therapeutic approach for t(8;21) AML.

Pubmed ID: 15735013


  • Liu S
  • Shen T
  • Huynh L
  • Klisovic MI
  • Rush LJ
  • Ford JL
  • Yu J
  • Becknell B
  • Li Y
  • Liu C
  • Vukosavljevic T
  • Whitman SP
  • Chang KS
  • Byrd JC
  • Perrotti D
  • Plass C
  • Marcucci G


Cancer research

Publication Data

February 15, 2005

Associated Grants

  • Agency: NCI NIH HHS, Id: K08-CA90469
  • Agency: NCI NIH HHS, Id: P30-CA16058
  • Agency: NCI NIH HHS, Id: R01-CA102031
  • Agency: NCI NIH HHS, Id: R21-CA094552

Mesh Terms

  • Acute Disease
  • Cell Line
  • Cell Line, Tumor
  • Core Binding Factor Alpha 2 Subunit
  • DNA (Cytosine-5-)-Methyltransferase
  • DNA Methylation
  • DNA-Binding Proteins
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Humans
  • Interleukin-3
  • Leukemia, Myeloid
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins
  • Transcription Factors
  • Transcription, Genetic
  • Transfection